Responsiveness to anti-PD-1 and anti-CTLA-4 immune checkpoint blockade in SB28 and GL261 mouse glioma models.
Oncoimmunology. 2018 Sep 5;7(12):e1501137. doi: 10.1080/2162402X.2018.1501137. eCollection 2018.
Oncoimmunology. 2018.
PMID: 30524896
Free PMC article.